AgomAb Therapeutics NV (AGMB) Discusses Open-Label Extension Results of Phase IIa STENOVA Study in Fibrosing Crohn’s Disease TranscriptOctober 2, 2026
Fed’s Kashkari says inflation is ‘still too high’ even after softer-than-expected PCE dataOctober 2, 2026
Higher claims pushed up non-life insurers’ underwriting losses: Report Finances December 24, 2022 Normal and well being insurers’ underwriting losses widened in FY22 when their incurred claims…
After poor show in Sept, non-life insurers’ premiums up 15.5% YoY in Oct Finances November 8, 2022 The non-life insurance coverage trade bounced again in October, as premiums grew at 15.51 per cent year-on-year (YoY) and…
